What it's for (Indications)
- Hydrochlorothiazide is a thiazide diuretic primarily indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive agents.
- Its efficacy in reducing blood pressure contributes significantly to the prevention of cardiovascular morbidity and mortality.
- Furthermore, it is widely used for the treatment of edema associated with various conditions, including congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and renal dysfunction such as nephrotic syndrome and acute glomerulonephritis.
- The therapeutic benefits arise from its ability to increase the excretion of sodium and water from the body, thereby reducing fluid volume and peripheral vascular resistance.
- This makes it a foundational medication in the long-term management of fluid overload and elevated blood pressure.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of hydrochlorothiazide must be individualized based on the patient's clinical response and tolerance. For the treatment of hypertension, the usual initial adult dosage is 25 mg once daily, which can be increased to 50 mg once daily if necessary. Doses above 50 mg typically do not provide significant additional antihypertensive effects and may increase the incidence of adverse reactions. For edema, the usual adult dosage ranges from 25 mg to 100 mg daily, administered as a single dose or in two divided doses, depending on the severity of the edema. Doses should be adjusted according to the patient's fluid and electrolyte balance. The maximum recommended daily dose for most indications is 100 mg. Lower doses may be required in elderly patients or those with impaired renal function. |
Safety & Warnings
Common Side Effects
- Hydrochlorothiazide can cause a range of side effects, both common and serious.
- Common adverse reactions include dizziness, lightheadedness, and orthostatic hypotension, particularly upon standing, due to fluid and electrolyte shifts.
- Electrolyte imbalances such as hypokalemia, hyponatremia, and hypochloremic alkalosis are frequently observed and require regular monitoring.
- Other notable side effects include hyperuricemia, which can precipitate gout attacks, and hyperglycemia, which may worsen glucose control in diabetic patients.
- Photosensitivity reactions, including rashes and increased sunburn risk, are also possible.
- More serious, albeit rare, adverse events include acute transient myopia, acute angle-closure glaucoma, bone marrow suppression, and hypersensitivity reactions such as Stevens-Johnson syndrome.
- Patients should be advised to report any persistent or severe symptoms promptly to their healthcare provider.
Serious Warnings
- Black Box Warning: Hydrochlorothiazide does not carry a formal FDA Black Box Warning. However, several serious warnings and precautions must be diligently observed to ensure patient safety and optimize therapeutic outcomes. **Serious Warnings:** 1. **Electrolyte Disturbances:** Hydrochlorothiazide can cause severe electrolyte imbalances, particularly hypokalemia, hyponatremia, hypomagnesemia, and hypochloremic alkalosis. These imbalances can be life-threatening and may precipitate cardiac arrhythmias, especially in patients with pre-existing cardiac conditions or those concurrently receiving digoxin. Regular monitoring of serum electrolytes is crucial, particularly during initiation of therapy and dose adjustments. 2. **Acute Myopia and Secondary Angle-Closure Glaucoma:** Hydrochlorothiazide has been rarely associated with an idiosyncratic reaction resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain, typically occurring within hours to weeks of drug initiation. If these symptoms occur, hydrochlorothiazide should be discontinued immediately. Prompt medical intervention is necessary to prevent permanent vision loss. 3. **Renal Impairment:** Thiazide diuretics may precipitate azotemia in patients with impaired renal function. The drug is largely ineffective when creatinine clearance is below 30 mL/min. Close monitoring of renal function is essential, and discontinuation may be required if progressive renal impairment becomes evident. 4. **Metabolic Effects:** Thiazides can elevate blood glucose levels, potentially unmasking latent diabetes mellitus or worsening glycemic control in diabetic patients. They can also increase serum uric acid, leading to hyperuricemia and possibly precipitating gout attacks. Lipid profiles may also be adversely affected.
- Patients receiving hydrochlorothiazide should be carefully monitored for fluid and electrolyte disturbances, especially hypokalemia, hyponatremia, and hypochloremic alkalosis, which can lead to cardiac arrhythmias.
- Caution is advised in patients with impaired renal function, as the drug's efficacy diminishes with severe renal impairment (creatinine clearance <30 mL/min), and it may exacerbate azotemia.
- In patients with hepatic impairment, hydrochlorothiazide can precipitate hepatic coma due to electrolyte and fluid imbalance.
- Diabetic patients should be closely monitored as thiazide diuretics can impair glucose tolerance.
- Patients with a history of gout or hyperuricemia require vigilant monitoring.
- Hydrochlorothiazide is a sulfonamide derivative, so caution is needed in patients with known sulfonamide allergies.
- It may also exacerbate systemic lupus erythematosus.
- Patients should be advised to avoid excessive sun exposure due to the risk of photosensitivity.
How it Works (Mechanism of Action)
Hydrochlorothiazide is a benzothiadiazine derivative that acts primarily in the distal convoluted tubule of the kidney. Its principal mechanism involves the inhibition of the sodium-chloride cotransporter (NCC) located on the apical membrane of the renal tubule cells. By blocking this cotransporter, hydrochlorothiazide prevents the reabsorption of approximately 5-10% of filtered sodium and chloride. This leads to an increased excretion of sodium, chloride, and water, along with potassium and hydrogen ions. The diuresis results in a reduction in plasma volume and, consequently, a decrease in cardiac output. Long-term antihypertensive effects are also attributed to a reduction in peripheral vascular resistance, possibly through a direct vasodilatory action or by reducing sodium content in vascular smooth muscle cells, thus decreasing their reactivity to vasoconstrictive stimuli.
Commercial Brands (Alternatives)
No other brands found for this formula.